| UniProt ID | TM9S4_HUMAN | |
|---|---|---|
| UniProt AC | Q92544 | |
| Protein Name | Transmembrane 9 superfamily member 4 | |
| Gene Name | TM9SF4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 642 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . Golgi apparatus . Early endosome . |
|
| Protein Description | Associates with proteins harboring glycine-rich transmembrane domains and ensures their efficient localization to the cell surface. [PubMed: 25999474 Regulates the assembly and activity of V-ATPase in colon cancer cells via its interaction with V-type proton ATPase subunit H (ATP6V1H) and contributes to V-ATPase-mediated pH alterations in cancer cells which play an important role in drug resistance and invasiveness of colon cancer cells] | |
| Protein Sequence | MATAMDWLPWSLLLFSLMCETSAFYVPGVAPINFHQNDPVEIKAVKLTSSRTQLPYEYYSLPFCQPSKITYKAENLGEVLRGDRIVNTPFQVLMNSEKKCEVLCSQSNKPVTLTVEQSRLVAERITEDYYVHLIADNLPVATRLELYSNRDSDDKKKEKDVQFEHGYRLGFTDVNKIYLHNHLSFILYYHREDMEEDQEHTYRVVRFEVIPQSIRLEDLKADEKSSCTLPEGTNSSPQEIDPTKENQLYFTYSVHWEESDIKWASRWDTYLTMSDVQIHWFSIINSVVVVFFLSGILSMIIIRTLRKDIANYNKEDDIEDTMEESGWKLVHGDVFRPPQYPMILSSLLGSGIQLFCMILIVIFVAMLGMLSPSSRGALMTTACFLFMFMGVFGGFSAGRLYRTLKGHRWKKGAFCTATLYPGVVFGICFVLNCFIWGKHSSGAVPFPTMVALLCMWFGISLPLVYLGYYFGFRKQPYDNPVRTNQIPRQIPEQRWYMNRFVGILMAGILPFGAMFIELFFIFSAIWENQFYYLFGFLFLVFIILVVSCSQISIVMVYFQLCAEDYRWWWRNFLVSGGSAFYVLVYAIFYFVNKLDIVEFIPSLLYFGYTALMVLSFWLLTGTIGFYAAYMFVRKIYAAVKID | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 46 | Ubiquitination | PVEIKAVKLTSSRTQ CEEEEEEEEECCCCC | 51.40 | - | |
| 68 | Ubiquitination | LPFCQPSKITYKAEN CCCCCCCCCEEEECC | 45.83 | - | |
| 72 (in isoform 1) | Ubiquitination | - | 40.34 | 21906983 | |
| 72 | Ubiquitination | QPSKITYKAENLGEV CCCCCEEEECCHHHH | 40.34 | 21890473 | |
| 81 | Methylation | ENLGEVLRGDRIVNT CCHHHHHCCCCEECC | 50.58 | 115918601 | |
| 88 | Phosphorylation | RGDRIVNTPFQVLMN CCCCEECCCHHHHCC | 18.00 | - | |
| 98 | Ubiquitination | QVLMNSEKKCEVLCS HHHCCCCCCEEEEEC | 63.65 | - | |
| 109 | Acetylation | VLCSQSNKPVTLTVE EEECCCCCCEEEEEE | 46.22 | 26051181 | |
| 112 | O-linked_Glycosylation | SQSNKPVTLTVEQSR CCCCCCEEEEEEHHH | 25.82 | OGP | |
| 126 | Phosphorylation | RLVAERITEDYYVHL HHHHHHCCCCCHHHH | 29.08 | 24043423 | |
| 129 | Phosphorylation | AERITEDYYVHLIAD HHHCCCCCHHHHHHC | 10.93 | 24043423 | |
| 130 | Phosphorylation | ERITEDYYVHLIADN HHCCCCCHHHHHHCC | 8.17 | 24043423 | |
| 142 | Phosphorylation | ADNLPVATRLELYSN HCCCCCCCHHHHCCC | 35.70 | 24043423 | |
| 147 | Phosphorylation | VATRLELYSNRDSDD CCCHHHHCCCCCCCC | 8.43 | 21406692 | |
| 148 | Phosphorylation | ATRLELYSNRDSDDK CCHHHHCCCCCCCCC | 37.70 | 21406692 | |
| 159 | Ubiquitination | SDDKKKEKDVQFEHG CCCCHHHHCCCCCCC | 72.57 | - | |
| 178 | Phosphorylation | FTDVNKIYLHNHLSF CCCCCEEEECCHHHE | 11.97 | - | |
| 188 | Phosphorylation | NHLSFILYYHREDME CHHHEEEEEEHHCCH | 7.75 | - | |
| 189 | Phosphorylation | HLSFILYYHREDMEE HHHEEEEEEHHCCHH | 7.31 | - | |
| 201 | Phosphorylation | MEEDQEHTYRVVRFE CHHHHCCEEEEEEEE | 16.57 | 20068231 | |
| 202 | Phosphorylation | EEDQEHTYRVVRFEV HHHHCCEEEEEEEEE | 11.88 | 20068231 | |
| 220 (in isoform 1) | Ubiquitination | - | 67.14 | 21906983 | |
| 220 | Ubiquitination | SIRLEDLKADEKSSC EECHHHHCCCCCCCC | 67.14 | 21890473 | |
| 224 | Ubiquitination | EDLKADEKSSCTLPE HHHCCCCCCCCCCCC | 48.49 | - | |
| 233 | O-linked_Glycosylation | SCTLPEGTNSSPQEI CCCCCCCCCCCCCCC | 30.20 | OGP | |
| 312 | Phosphorylation | LRKDIANYNKEDDIE HHHHHHCCCCCCCHH | 20.70 | 22817900 | |
| 314 (in isoform 1) | Ubiquitination | - | 52.76 | 21906983 | |
| 314 | Ubiquitination | KDIANYNKEDDIEDT HHHHCCCCCCCHHHH | 52.76 | 21890473 | |
| 340 | Phosphorylation | DVFRPPQYPMILSSL CCCCCCCHHHHHHHH | 10.67 | 24043423 | |
| 345 | Phosphorylation | PQYPMILSSLLGSGI CCHHHHHHHHHCCHH | 14.17 | 24043423 | |
| 346 | Phosphorylation | QYPMILSSLLGSGIQ CHHHHHHHHHCCHHH | 24.94 | 24043423 | |
| 350 | Phosphorylation | ILSSLLGSGIQLFCM HHHHHHCCHHHHHHH | 32.46 | 22210691 | |
| 371 | Phosphorylation | VAMLGMLSPSSRGAL HHHHHCCCHHHHHHH | 17.53 | 20068231 | |
| 373 | Phosphorylation | MLGMLSPSSRGALMT HHHCCCHHHHHHHHH | 29.32 | 22210691 | |
| 374 | Phosphorylation | LGMLSPSSRGALMTT HHCCCHHHHHHHHHH | 37.81 | 28176443 | |
| 396 | Phosphorylation | MGVFGGFSAGRLYRT HHHHCCCCHHHHHHH | 32.84 | 18452278 | |
| 474 | Ubiquitination | GYYFGFRKQPYDNPV HHHHCCCCCCCCCCC | 54.05 | 21890473 | |
| 474 (in isoform 1) | Ubiquitination | - | 54.05 | 21906983 | |
| 636 | Phosphorylation | YMFVRKIYAAVKID- HHHHHHHHHHHCCC- | 7.49 | 22817900 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM9S4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM9S4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM9S4_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-312, AND MASSSPECTROMETRY. | |